Max Marinescu

Mr. Max Marinescu

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 1999 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
HCHoria Chiriac
Horia Chiriac
MMMax Marinescu
Max Marinescu
KBK.H.J Buschow
K.H.J Buschow
FBF.R de Boer
F.R de Boer
EBEkkes BRUCK
Ekkes BRUCK

11 December 2023 in Materials
Verified
Journal Article
Open access
PDF file
HPHadrian Platzer
Hadrian Platzer
MMMax Marinescu
Max Marinescu
QNQaisar Nawaz
Qaisar Nawaz
ETElena Tripel
Elena Tripel
SGSimone Gantz
Simone Gantz
Fabian WesthauserFabian Westhauser
Fabian Westhauser
Synovial inflammation in osteoarthritis (OA) is characterized by the release of cartilage-degrading enzymes and inflammatory cytokines. 45S5-bioactive glass (45S5-BG) can modulate inflammation processes; however, its influence on OA-associated inflammation has hardly been investigated. In this study, the effects of 45S5-BG on the release of cartilage-degrading metalloproteinases and cytokines from synovial membrane cells (SM) isolated from patients with knee OA was assessed in vitro. SM were cultivated as SM monocultures in the presence or absence of 45S5-BG. On day 1 (d1) and d7 (d7), the concentrations of Matrix Metalloproteinases (MMPs) and cytokines were assessed. In 45S5-BG-treated SM cultures, MMP9 concentration was significantly reduced at d1 and d7, whilst MMP13 was significantly increased at d7. Concentrations of interleukin (IL)-1B and C-C motif chemokine ligand 2 (CCL2) in 45S5-BG-treated SM cultures were significantly increased at both time points, as were interferon gamma (IFNG) and IL-6 at d7. Our data show an effect of 45S5-BG on SM activity, which was not clearly protective, anti-inflammatory, or pro-inflammatory. The influence of 45S5-BG on MMP release was more suggestive of a cartilage protective effect, but 45S5-BG also increased the release of pro-inflammatory cytokines. Further studies are needed to analyze the effect of BGs on OA inflammation, including the anti-inflammatory modification of BG compositions.

Verified
Journal Article
Open access
PDF file
MMMax Marinescu
Max Marinescu
SHSebastien Hagmann
Sebastien Hagmann
JFJoerg Fellenberg
Joerg Fellenberg
ETElena Tripel
Elena Tripel
SGSimone Gantz
Simone Gantz
HPHadrian Platzer
Hadrian Platzer
Osteoarthritis (OA), the most common joint disease, is marked by cartilage degradation and chronic inflammation. While 45S5-bioactive glass (45S5-BG) is well-established in bone regeneration and has been suggested to exert immunomodulatory effects, its impact on OA chondrocytes remains largely unexplored. Therefore, this in vitro study investigated the effects of 45S5-BG microparticles (0.125 mg/mL) on chondrocytes derived from OA patients, evaluating its therapeutic potential in OA. Chondrocytes were cultured with or without 45S5-BG for 1 and 7 days. Gene expression of cartilage markers, cytokines, matrix metalloproteinases (MMPs), and toll-like receptors (TLRs) was analyzed by qPCR. Protein levels were assessed by ELISA. 45S5-BG stimulation significantly altered chondrocyte activity, inducing upregulation of IL-6, IL-1β, TNF-α, MMP-1/-3/-13, and TLR4. Expression of ACAN and COL2A1 was reduced, while COL10A1—a marker of chondrocyte hypertrophy—was significantly increased at day 1. These findings show a catabolic and pro-inflammatory shift in chondrocyte phenotype upon 45S5-BG exposure, showing no therapeutic benefit of 45S5-BG on OA chondrocytes. However, considering the pronounced effects on chondrocyte activity and the well-established bioactivity and biocompatibility of 45S5-BG, our findings suggest that modified BG formulations could be developed to enhance chondroprotective and anti-inflammatory properties, warranting further investigation in co-culture and in vivo models.

20 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
JFJoerg Fellenberg
Joerg Fellenberg
SLSarina Losch
Sarina Losch
MMMax Marinescu
Max Marinescu
BFBirgit Frey
Birgit Frey
BLBurkhard Lehner
Burkhard Lehner
Fabian WesthauserFabian Westhauser
Fabian Westhauser
Tumor recurrence is a major problem during the treatment of giant cell tumors of bone (GCTB). We recently identified tumor cell-specific cytotoxic effects of bioactive glasses (BGs) toward neoplastic stromal cells derived from GCTB tissue (GCTSCs) in vitro. Since these data indicated a promising role of BGs in the adjuvant treatment of GCTBs, we aimed to investigate the transferability of the in vitro data into the more complex in vivo situation in the current study. We first analyzed the cytotoxicity of three different BGs in vitro by WST-1 assay after co-cultivation with primary GCTSC cell lines. The effects of BGs on tumor engraftment and growth were analyzed by chicken chorioallantoic membrane (CAM) assays and subsequent quantification of tumor take rates and tumor volumes. In vitro, all tested BGs displayed a cytotoxic effect on GCTSCs that was dependent on BG composition, concentration, and particle size. Comparable effects could be observed within the in vivo environment resulting in reduced tumor take rates and tumor volumes in BG-treated samples. These data indicate a possible clinical application of BGs in the context of GCTB therapy, mediating a reduction of recurrence rates with the simultaneous promotion of bone regeneration.

1 August 2001 in Materials Science Forum
Verified
Journal Article
Closed access
PDF file
HCHoria Chiriac
Horia Chiriac
CMC.S. Marinescu
C.S. Marinescu
MMMax Marinescu
Max Marinescu

28 March 2022 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
MMMax Marinescu
Max Marinescu
TRT. Renkawitz
T. Renkawitz
ETE. Tripel
E. Tripel
ABA.R. Boccaccini
A.R. Boccaccini
BMB. Moradi
B. Moradi
HPHadrian Platzer
Hadrian Platzer